Barinthus Biotherapeutics plc (BRNS) support and resistance · $38.2M cap
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
This page maps Barinthus Biotherapeutics plc (BRNS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BRNS revenue for 2025-09-30 was $0. Net income was -$14.6M. BRNS currently screens at market cap $38.2M.
BRNS currently screens at market cap $38.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BRNS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BRNS quote page for the session range and the stock page for the full model.
Not investment advice.